Skip to main content

Increase in polymorphonuclear myeloid‑derived suppressor cells and regulatory T‑cells in children with B‑cell acute lymphoblastic leukemia

Research Abstract

Our study aimed to evaluate the levels of MDSCs and Tregs in pediatric B-cell acute lymphoblastic
leukemia (B-ALL), their relation to patients’ clinical and laboratory features, and the impact of these
cells on the induction response. This study included 31 pediatric B-ALL patients and 27 healthy
controls. All patients were treated according to the protocols of the modified St. Jude Children’s
Research Hospital total therapy study XIIIB for ALL. Levels of MDSCs and Tregs were analyzed using
flow cytometry. We observed a reduction in the levels of CD4 + T-cells and an increase in both the
polymorphonuclear MDSCs (PMN-MDSCs) and Tregs. The frequencies of PMN-MDSCs and Tregs were
directly related to the levels of peripheral and bone marrow blast cells and CD34 + cells. Complete
postinduction remission was associated with reduced percentages of PMN-MDSCs and Tregs, with
the level of PMN-MDCs in this subpopulation approaching that of healthy controls. PMN-MDSCs and
Tregs jointly play a critical role in maintaining an immune-suppressive state suitable for B-ALL tumor
progression. Thereby, they could be independent predictors of B-ALL progress, and finely targeting
both PMN-MDSCs and Tregs may be a promising approach for the treatment of B-ALL.

Research Authors
Asmaa M. Zahran1, Azza Shibl2, Amal Rayan3, Mohamed Alaa Eldeen Hassan Mohamed3, Amira M. M. Osman2, Khaled Saad 4*, Khaled Hashim Mahmoud4, Aliaa M. A. Ghandour5, Khalid I. Elsayh4 & Omnia El‑Badawy5
Research Date
Research Department
Research Journal
Scientific Reports
Research Pages
15-39
Research Publisher
natureportfolio
Research Vol
11
Research Website
| https://doi.org/10.1038/s41598-021-94469-x
Research Year
2021

Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom

Research Abstract

Background and Objectives: Risk-adapted therapy for children with HL is
directed toward high survival, minimal toxicity and optimal quality of life,
with long term follow up. We assess the impact of prognostic factors associated
with local treatment failure of pediatric HL patients with unfavorable
criteria treated with combined modality: Alternating ABVD (Doxorubicin,
Bleomycin, Vinblastine and Decarbazine) and COEP (Cyclophosphamide,
Oncovin, Etoposide and Prednisone) chemotherapy and response-based, involved-
field radiation for newly diagnosed unfavorable pediatric HL patients,
also will detect toxicities and long-term complications observed in the patients.
Methods: This prospective study was carried out from January 2010 to
January 2018, with a median follow up of 74 months (range 8 - 103 months).
54 patients were eligible for this study stratified into two groups: intermediate
risk (IR) and high-risk group (HR). Patients were treated with (4 - 6 cycles)
and (6 - 8 cycles) respectively of alternating ABVD/COEP chemotherapy followed
by involved-field radiation therapy (IFRT): 15 Gy for patients achieved
complete response, and 25.5 Gy for those achieved a partial response. Results:
27 patients were IR and 27 patients were HR. There were 16 treatment failures;
5 patients had progressive disease; and 11 patients had a relapse. 9 patients
died from their disease progression. The 5-year overall survival (OS)
and event-free survival (EFS) rates (±SE) were 81.8% ± 5.7% and 71.8% ±
6.2% respectively. Multivariate analysis revealed that the only independent
factor for inferior OS was radiotherapy. Conclusion: Treatment results of
unfavourable HL patients in our study are satisfactory for with IR group but
not for HR group who needs intensification of therapy. Radiotherapy is considered
as a cornerstone in the treatment of the patients with unfavourable
How to cite this paper: Ali, A.M., Mo

Research Authors
Amany M. Ali1, Amira M. Mohamed1, Shimaa Ahmed2*, Mohamed Abdallah3, Tarek M. Alsaba4, Saamer Mansour5
Research Date
Research Department
Research File
final paper_0.pdf (523.34 KB)
Research Journal
journal of cancer therapy
Research Pages
545-558
Research Publisher
scienitific Research Publisher
Research Vol
9
Research Website
https://doi.org/10.4236/jct.2018.97046
Research Year
2018

Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia

Research Authors
Sayed NG 1 , Mokhtar AA 1 , Farag MR 1 , Shibl A 2 , Hafez R 3 , Hussein S 3 , Bakry RM 1 ,
Research Department
Research Journal
SECI Oncology
Research Member
Research Pages
86-94
Research Publisher
South Egypt Cancer Institute
Research Rank
محلى
Research Vol
10
Research Year
2022

Pattern and Outcome of Neurological Complications During the Treatment of Pediatric Acute Leukemias in Upper Egypt

Research Authors
Heba A. Sayed 1 , Radwa M. Hussein 1 , Haisam Atta 2 , Mohamed A. Abdelhamed 3 , Azza Shibl 1
Research Department
Research File
Research Journal
Research in Oncology
Research Member
Research Pages
29-36
Research Publisher
Cairo University, Faculty of Medicine, Kasr Al-Ainy Center of Clinical Oncology & Nuclear Medicine
Research Rank
محلى
Research Vol
18
Research Website
DOI: 10.21608/resoncol.2021.77935.1145
Research Year
2022

First Relapse of Acute Lymphoblastic Leukemia in Children in Upper Egypt: Survival Outcome and Prognostic Factors

Research Authors
Azza Shibl 1 , Heba A. Sayed 1 , Asmaa M. Zahran 2
Research Department
Research File
Research Journal
Research in Oncology
Research Member
Research Pages
51-59
Research Publisher
Cairo University, Faculty of Medicine, Kasr Al-Ainy Center of Clinical Oncology & Nuclear Medicine
Research Rank
محلى
Research Vol
17
Research Website
https://dx.doi.org/10.21608/resoncol.2021.75528.1144
Research Year
2021

Assessment of Humoral Immune Recovery in Children with Hematological malignancies after Completion of Chemotherapy

Research Authors
Sayed HA 1 , Sayed DM 2 , Mohammed RT 1 , Sayed AS 1 .
Research Department
Research Journal
SECI Oncology
Research Member
Research Pages
170-177
Research Publisher
South Egypt Cancer Institute
Research Rank
محلى
Research Vol
9(3)
Research Website
https://dx.doi.org/10.21608/secioj.2021.196041
Research Year
2021

Two-be SPECT/CT versus planar bone scintigraphy: Prospective comparison of reproducibility and diagnostic performance

Research Authors
Rehab Mostafa
Research Date
Research Journal
Nuclear Medicine Communications
Research Pages
360-368
Research Publisher
Wolters Kluwer Health
Research Vol
42
Research Year
2021

Feasibility of dual-phase 99mTc-MDP SPECT/CT imaging in rheumatoid arthritis evaluation

Research Abstract

Background

To prospectively demonstrate the feasibility of performing dual-phase SPECT/CT for the assessment of the small joints of the hands of rheumatoid arthritis (RA) patients, and to evaluate the reliability of the quantitative and qualitative measures derived from the resulting images.

Methods

A SPECT/CT imaging protocol was developed in this pilot study to scan both hands simultaneously in participants with RA, in two phases of 99mTc-MDP radiotracer uptake, namely the soft-tissue blood pool phase (within 15 minutes after radiotracer injection) and osseous phase (after 3 hours). Joints were evaluated qualitatively (normal vs. abnormal uptake) and quantitatively [by measuring a newly developed metric, maximum corrected count ratio (MCCR)]. Qualitative and quantitative evaluations were repeated to assess reliability.

Results

Four participants completed seven studies (all four were imaged at baseline, and three of them at follow-up after 1-month of arthritis therapy). A total of 280 joints (20 per hand) were evaluated. The MCCR from soft-tissue phase scans was significantly higher for clinically abnormal joints compared to clinically normal ones; P<0.001, however the MCCR from the osseous phase scans were not different between the two joint groups. Intraclass Correlation Coefficient (ICC) for MCCR was excellent [0.9789, 95% confidence interval (CI): 0.9734–0.9833]. Intra-observer agreement for qualitative SPECT findings was substantial for both the soft-tissue phase (kappa =0.78, 95% CI: 0.72–0.83) and osseous-phase (kappa =0.70, 95% CI: 0.64–0.76) scans.

Conclusions

Extracting reliable quantitative and qualitative measures from dual-phase 99mTc-MDP SPECT/CT hand scans is feasible in RA patients. SPECT/CT may provide a unique means for assessing both synovitis and osseous involvement in RA joints using the same radiotracer injection.

Research Authors
Yasser G Abdelhafez, Felipe Godinez, Kanika Sood, Rosalie J Hagge, Robert D Boutin, Siba P Raychaudhuri, Ramsey D Badawi, Abhijit J Chaudhari
Research Date
Research Journal
Quantitative Imaging in Medicine and Surgery
Research Member
Research Pages
2333–2343
Research Rank
1
Research Vol
vol.11
Research Year
2021

Expression of programmed death ligand-1 (PDL-1) in Acute Myeloid Leukemia Patients and its relation to post induction

Research Abstract

Background and aim: In spite of approval of new therapeutic modalities, the clinical outcome of patients with acute myeloid leukemia (AML) remains unsatisfactory. Accurate risk stratification of patients is crucial for improving their outcome. Programmed death receptor-ligand 1 (PD-L1) plays an important role in the progression of malignant disorders. So we aimed to analyze PD-L1 expression on AML cells by flow cytometry and its relation to post induction response.

Research Authors
LA Abdel Hafeez, SG Mansor, AM Zahran, HB Hamed, MR Abdel Hameed, RM Bakry
Research Department
Research Journal
SECI Oncology
Research Year
2021
Subscribe to